ConductScience.org, home

Paper28596207

Delayed progression of bull's eye maculopathy.

Jain S and 1 other. BMJ Case Rep, 2017. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Delayed progression of bull's eye maculopathy. Papers, record 28596207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28596207

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Delayed progression of bull's eye maculopathy.
PubMed
Journal
BMJ Case Rep
PubMed
Year
2017
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2020-02-25
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jain SSunila
2Jain NGNeel Gautam

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antirheumatic AgentsMajor topic
ChloroquineMajor topic
Macular DegenerationMajor topic
Retinal DiseasesMajor topic
Aftercare
Aged
Disease Progression
Electroretinography
Female
Fluorescein Angiography
Humans
Outcome Assessment, Health Care
Tomography, Optical Coherence
Vision Disorders
Visual Acuity

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117264974Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration?Clin Rheumatol2007https://conductscience.org/library/papers/17264974PubMed
223580861Delayed onset chloroquine retinopathy presenting 10 years after long-term usage of chloroquine.Middle East Afr J Ophthalmol2013https://conductscience.org/library/papers/23580861PubMed
324187053Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation.Br J Ophthalmol2014https://conductscience.org/library/papers/24187053PubMed
424922444Effect of disease stage on progression of hydroxychloroquine retinopathy.JAMA Ophthalmol2014https://conductscience.org/library/papers/24922444PubMed
525275721The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.JAMA Ophthalmol2014https://conductscience.org/library/papers/25275721PubMed
626992838Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).Ophthalmology2016https://conductscience.org/library/papers/26992838PubMed
73964626Delayed-onset chloroquine retinopathy.Br J Ophthalmol1986https://conductscience.org/library/papers/3964626PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
37767541Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis.World J Exp Med2023https://conductscience.org/library/papers/37767541PubMed
37418250Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy: One Year Follow-Up.Transl Vis Sci Technol2023https://conductscience.org/library/papers/37418250PubMed
36412828Knowledge of Saudi Patients with Autoimmune Diseases about Hydroxychloroquine Toxicity: The Role of Physician-Patient Communication.Pharmacy (Basel)2022https://conductscience.org/library/papers/36412828PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28596207

GET https://conductscience.org/api/papers/v1/28596207/authors